Aspyra

APYI

Medical - Healthcare Information Services · Healthcare

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 23, 2026 · filings through Sep 30, 2009

How the score breaks down

Quality

Strong

Growth

Weak

Cash Flow

Weak

Stability

Good

Valuation

Data not available

Track this stock — start free trial

Winston Score History

The full picture

Aspyra Inc. is a small healthcare technology company that makes software for medical facilities. Its core products are information systems used by hospitals, clinics, and diagnostic imaging centers to manage patient records, orders, and test results. The company operates in the healthcare information services industry, focusing on tools that help medical staff organize and share clinical data.

Aspyra earns revenue primarily by selling software licenses and providing related support and maintenance services to its healthcare customers, which gives it a recurring revenue component. The company is small, with a market cap near zero, and operates mainly in the United States. Its gross and operating margins are relatively high for its size, suggesting low variable costs once software is deployed, but being a very small player in a market dominated by much larger vendors like Epic and Oracle Health is a significant competitive risk. The main challenge Aspyra faces is winning and keeping customers against well-funded rivals with broader product offerings.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-16.9% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-59.6% YoY

YoY Growth Rate

Earnings declining

Insider Activity

36.9%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~4 months

$564,862 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Aspyra has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

37.6%

Modest — 37.6% gross margin

Profit after running costs

Operating Margin

56.2%

Excellent — 56.2% operating margin

Return on the money invested

ROCE

60.6%

Exceptional — 60.6% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-15.6%

Shrinking sales (-15.6% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

1/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-30.7%

Burning cash (-30.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

1.04

Elevated debt (1.04)

Covers its interest

Interest Cover

4.05x

Adequate interest coverage (4.0x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial